Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Freund

Showing results (401-410 of 408) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 408 results.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
Plos Neglected Tropical Diseases|January 28, 2020
In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontisAlexandra Ehrens, Christopher S Lunde, Robert T Jacobs, et al.
Cell Stem Cell|December 1, 2020
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair ResponseArunima Purkayastha, Chandani Sen, Gustavo Garcia, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked AnalogsDavid S Carter, Robert T Jacobs, Yvonne R Freund, et al.
Nature Communications|March 7, 2017
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologueEbere Sonoiki, Caroline L Ng, Marcus C S Lee, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Pageof 41

Showing results (401-410 of 408) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 408 results.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
Plos Neglected Tropical Diseases|January 28, 2020
In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontisAlexandra Ehrens, Christopher S Lunde, Robert T Jacobs, et al.
Cell Stem Cell|December 1, 2020
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair ResponseArunima Purkayastha, Chandani Sen, Gustavo Garcia, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked AnalogsDavid S Carter, Robert T Jacobs, Yvonne R Freund, et al.
Nature Communications|March 7, 2017
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologueEbere Sonoiki, Caroline L Ng, Marcus C S Lee, et al.
ACS Infectious Diseases|December 27, 2019
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked AnalogsTsutomu Akama, Yvonne R Freund, Pamela W Berry, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteriaVincent Hernandez, Thibaut Crépin, Andrés Palencia, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Pageof 41